Xiuzhen Zhang
389 Xincun Rd
Xincun, 200065, China
Xincun, 200065, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Treatment of postmenopausal osteoporosis with recombinant human parathyroid hormone and electromagnetic field.
Journal: Aging clinical and experimental research
Published: November 24, 2024
Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial.
Journal: Current medical research and opinion
Published: July 14, 2022
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial.
Journal: Nature medicine
Published: July 19, 2021
Efficacy and Safety of Mulberry Twig Alkaloids Tablet for the Treatment of Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Clinical Trial.
Journal: Diabetes care
Published: August 24, 2020
Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.
Journal: Journal of diabetes investigation
Published: May 07, 2020
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS).
Journal: Science bulletin
Published: February 27, 2020
Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Journal: Journal of bone and mineral metabolism
Published: May 16, 2017
Wnt/β-catenin signaling in osteoblasts regulates global energy metabolism.
Journal: Bone
Published: November 12, 2016
Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naïve Asian patients with type 2 diabetes.
Journal: Diabetes research and clinical practice
Published: February 19, 2016
Differential therapeutic effects of nateglinide and acarbose on fasting and postprandial lipid profiles: a randomized trial.
Journal: Diabetes technology & therapeutics
Published: March 18, 2015
Association of LRP5 gene polymorphism with type 2 diabetes mellitus and osteoporosis in postmenopausal women.
Journal: International journal of clinical and experimental medicine
Published: November 19, 2013
Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in chinese antihyperglycemic agent-naive subjects with type 2 diabetes.
Journal: Diabetes technology & therapeutics
Published: May 02, 2013
Last Updated: 09/26/2026